Each year, the Rutgers Cancer Institute of New Jersey selects a promising new investigator in the field of cancer research to receive an award to support their research.
Dr. Valvezan's continued research efforts studying the regulation and function of mTORC1 in cell growth and cancer are of great importance to the Cancer Metabolism and Growth Program (CMG).